Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128a1 · Date: 20260120 · State: MO
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
25,890
Total Claims
$1.6M
Drug Cost
911
Beneficiaries
$1,776
Cost/Patient
Risk Score Breakdown 47/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+87%
Opioid rate vs peers
4.8% vs 2.6% avg
+66%
Cost per patient vs peers
$1,776 vs $1,068 avg
+33%
Brand preference vs peers
12.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.8%
Opioid Rate
1,251
Opioid Claims
$27K
Opioid Cost
4.6%
Long-Acting Rate
Brand vs Generic
Brand: 3,074 claims · $1.1M
Generic: 22,589 claims · $485K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 636 | $184K |
| Teriflunomide | 12 | $120K |
| Rifaximin | 17 | $54K |
| Rivaroxaban | 149 | $52K |
| Aripiprazole Lauroxil | 14 | $44K |
| Insulin Glargine,hum.Rec.Anlog | 147 | $41K |
| Mirabegron | 122 | $35K |
| Aripiprazole | 12 | $34K |
| Empagliflozin | 105 | $32K |
| Sitagliptin Phosphate | 81 | $26K |
| Insulin Lispro | 51 | $24K |
| Insulin Aspart | 59 | $21K |
| Tiotropium Bromide | 28 | $20K |
| Fluticasone/Vilanterol | 47 | $20K |
| Budesonide/Formoterol Fumarate | 46 | $18K |
Prescribing Profile
Patient Profile
78
Avg Age
65%
Female
1.98
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About